Parkinson's disease is a progressive neurological disorder affecting nearly 1 million people in the United States. It is caused by a lack of dopamine-producing nerve cells in the brain. Symptoms of Parkinson's disease can include tremor, rigidity, slow movement, and difficulty with balance and walking. The severity of symptoms varies from person to person but can worsen with time. There is no known cure for Parkinson's disease, but medications and lifestyle changes can help manage symptoms and slow the progression of the disease. Levodopa is a central component of medication therapy for Parkinson's disease and is one of the most commonly prescribed medications for this condition. It works by helping the body produce dopamine, a neurotransmitter that is essential for the proper functioning of the central nervous system and movement. Levodopa is often combined with other medications, such as carbidopa, to improve efficacy and lessen side effects. These medications can improve daily functioning, such as allowing individuals to walk without assistance, and allow for faster and more coordinated movement. Recent advancements in treating Parkinson's disease include deep brain stimulation (DBS) and gene therapy. DBS involves surgically implanting an electronic device in the brain that sends electrical signals to areas believed to be associated with the symptoms of Parkinson's. These electrical signals can help reduce tremors and other motor symptoms. Gene therapy is another form of treatment that involves introducing genes into the body, specifically targeting areas of the brain that are affected by Parkinson's. While these treatments can be effective, they often come with risks and must be customized for each person's specific needs. Exercise is also an important component of managing Parkinson's disease. Regular physical activity can help improve mobility and daily functioning, as well as reduce fatigue. Exercise may also help to slow the long-term progression of the disease. Some people may also benefit from physical or occupational therapy to reduce symptoms and improve quality of life. Additionally, talk-therapy may be beneficial for those with Parkinson's to address depression, anxiety, and stress.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom